Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study

Autor: Daniel Modin, Brian Claggett, Mads Emil Jørgensen, Lars Køber, Thomas Benfield, Morten Schou, Jens‐Ulrik Stæhr Jensen, Scott D. Solomon, Ramona Trebbien, Michael Fralick, Orly Vardeny, Marc A. Pfeffer, Christian Torp‐Pedersen, Gunnar Gislason, Tor Biering‐Sørensen

Publikováno v: Modin, D, Claggett, B, Jørgensen, M E, Køber, L, Benfield, T, Schou, M, Jensen, J U S, Solomon, S D, Trebbien, R, Fralick, M, Vardeny, O, Pfeffer, M A, Torp-Pedersen, C, Gislason, G & Biering-Sørensen, T 2022, ' Flu Vaccine and Mortality in Hypertension : A Nationwide Cohort Study ', Journal of the American Heart Association, vol. 11, no. 6, e021715 . https://doi.org/10.1161/JAHA.121.021715
Modin, D, Claggett, B, Jørgensen, M E, Køber, L, Benfield, T, Schou, M, Jensen, J-U S, Solomon, S D, Trebbien, R, Fralick, M, Vardeny, O, Pfeffer, M A, Torp-Pedersen, C, Gislason, G & Biering-Sørensen, T 2022, ' Flu Vaccine and Mortality in Hypertension : A Nationwide Cohort Study ', Journal of the American Heart Association, vol. 11, no. 6, e021715 . https://doi.org/10.1161/JAHA.121.021715

Background Influenza infection may increase the risk of stroke and acute myocardial infarction (AMI). Whether influenza vaccination may reduce mortality in patients with hypertension is currently unknown. Methods and Results We performed a nationwide

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dba81899b9a60c3c2573e1c61c600aed
https://doi.org/10.1161/jaha.121.021715

Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro

Autor: Caroline Tapparel, Thomas Cerny, Chiara Medaglia, Andreas Cerny, Erich H Cerny, Valeria Cagno, Arnaud Charles-Antoine Zwygart

Publikováno v: Scientific Reports, Vol. 11, No 1 (2021) P. 14295
Scientific reports, vol. 11, no. 1, pp. 14295
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports

Methylene blue is an FDA (Food and Drug Administration) and EMA (European Medicines Agency) approved drug with an excellent safety profile. It displays broad-spectrum virucidal activity in the presence of UV light and has been shown to be effective i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6020a29ad34beedd3ef3bc09748b0f69
https://archive-ouverte.unige.ch/unige:154384

Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection

Autor: Venkatesan, Sudhir, Myles, Puja R, Bolton, Kirsty J, Muthuri, Stella G, Al Khuwaitir, Tarig, Anovadiya, Ashish P, Azziz-Baumgartner, Eduardo, Bajjou, Tahar, Bassetti, Matteo, Beovic, Bojana, Bertisch, Barbara, Bonmarin, Isabelle, Booy, Robert, Borja-Aburto, Victor H, Burgmann, Heinz, Cao, Bin, Carratala, Jordi, Chinbayar, Tserendorj, Cilloniz, Catia, Denholm, Justin T, Dominguez, Samuel R, Duarte, Pericles A D, Dubnov-Raz, Gal, Fanella, Sergio, Gao, Zhancheng, Gérardin, Patrick, Giannella, Maddalena, Gubbels, Sophie, Herberg, Jethro, Higuera Iglesias, Anjarath Lorena, Hoeger, Peter H, Hu, Xiao Yun, Islam, Quazi T, Jiménez, Mirela F, Keijzers, Gerben, Khalili, Hossein, Kusznierz, Gabriela, Kuzman, Ilija, Langenegger, Eduard, Lankarani, Kamran B, Leo, Yee-Sin, Libster, Romina P, Linko, Rita, Madanat, Faris, Maltezos, Efstratios, Mamun, Abdullah, Manabe, Toshie, Metan, Gokhan, Mickiene, Auksė, Mikić, Dragan, Mohn, Kristin G I, Oliva, Maria E, Ozkan, Mehpare, Parekh, Dhruv, Paul, Mical, Rath, Barbara A, Refaey, Samir, Rodríguez, Alejandro H, Sertogullarindan, Bunyamin, Skręt-Magierło, Joanna, Somer, Ayper, Talarek, Ewa, Tang, Julian W, To, Kelvin, Tran, Dat, Uyeki, Timothy M, Vaudry, Wendy, Vidmar, Tjasa, Zarogoulidis, Paul, Nguyen-Van-Tam, Jonathan S, PRIDE Consortium Investigators

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
The Journal of Infectious Diseases, Vol. 221, No 3 (2020) pp. 356-366
The Journal of Infectious Diseases

Background The effect of neuraminidase inhibitor (NAI) treatment on length of stay (LoS) in patients hospitalized with influenza is unclear. Methods We conducted a one-stage individual participant data (IPD) meta-analysis exploring the association be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d22036bddd26ca3b77ef3c8ccdf6a23f
https://pubmed.ncbi.nlm.nih.gov/31106811

ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

Autor: Arnaud G, L'Huillier, Kuntheavy, Ing Lorenzini, Pierre-Alex, Crisinel, Michela C, Rebsamen, Joel, Fluss, Christian M, Korff, Remy P, Barbe, Claire-Anne, Siegrist, Pierre, Dayer, Klara M, Posfay-Barbe, Jules A, Desmeules, Barbara, Wildhaber

Publikováno v: Pharmacogenomics, Vol. 12, No 10 (2011) pp. 1493-501

Aims: To examine the safety profile of oseltamivir in children and evaluate the impact of P-glycoprotein polymorphisms on the incidence of neuropsychiatric adverse events (NPAE) in oseltamivir-treated children. Subjects & methods: This prospective co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e335991f1b1fd8380767f82c87c012f8
https://pubmed.ncbi.nlm.nih.gov/21902503

Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus

Autor: Sophia Ng, Kwok H. Chan, Dennis K. M. Ip, Peter M. Houck, Vicky J. Fang, J. S. Malik Peiris, Benjamin J. Cowling, Gabriel M. Leung, Timothy M. Uyeki, Calvin K. Y. Cheng

Publikováno v: Clinical Infectious Diseases

Background. Large clinical trials have demonstrated the therapeutic efficacy of oseltamivir against influenza. We assessed the indirect effectiveness of oseltamivir in reducing secondary household transmission in an incident cohort of influenza index

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf935811e932ed77e45e173e8db49462
http://hdl.handle.net/10722/86785